Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

This study has been completed.
Information provided by:
University Hospital, Bonn Identifier:
First received: August 1, 2007
Last updated: June 14, 2012
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):